“EXPLORATION OF HYDROXYL SUBSTITUTED REGORAFENIB DERIVATIVES AS A TYROSINE KINASE INHIBITORS OF LEUKIMIA THROUGH MOLECULAR DOCKING”. 2026. Frontier in Medical and Health Research 4 (3): 3863-74. https://fmhr.net/index.php/fmhr/article/view/3740.